Comparison of Dural Puncture Epidural Versus Conventional Epidural for Labour Analgesia in Primigravida
Launched by SOHAG UNIVERSITY · Jan 5, 2025
Trial Information
Current as of July 21, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at two different methods for providing pain relief during labor for first-time mothers. The two techniques being compared are the Dural Puncture Epidural (DPE) and the Conventional Epidural (CE). The goal is to see which method is more effective and safe for managing labor pain in women who are pregnant for the first time.
To participate in this study, women must be between the ages of 18 and 40, in their 37th to 42nd week of pregnancy, and in active labor with less than 5 cm of cervical dilation. They need to be healthy with no serious medical conditions and agree to take part in the study. If eligible, participants can expect to receive either the DPE or CE method of pain relief during labor, and their experiences will be closely monitored to help determine which method works better. This trial is not yet recruiting participants, so further information will be available once it begins.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Primigravida women aged 18-40 years.
- • 2. Gestational age between 37 and 42 weeks.
- • 3. Single pregnancy with vertex presentation.
- • 4. Patients in active labor with cervical dilation of less than 5 cm at the time of epidural placement.
- • 5. American Society of Anesthesiologist physical status I or II.
- • 6. Patients who provide informed consent for participation in the study.
- Exclusion Criteria:
- • 1. Patients with contraindications to neuraxial anesthesia (e.g., coagulopathy, infection at the puncture site).
- • 2. History of preeclampsia, gestational diabetes, or any other significant medical conditions that could influence labor or anesthesia outcomes.
- • 3. Patients with a history of previous uterine surgery, including cesarean section.
- • 4. Known fetal anomalies or non- vertex presentations.
- • 5. Patients with morbid obesity (BMI \> 40 kg/m²).
- • 6. Allergy or hypersensitivity to local anesthetic-s used in the study.
About Sohag University
Sohag University is a distinguished academic institution located in Sohag, Egypt, committed to advancing healthcare through rigorous clinical research. As a clinical trial sponsor, the university leverages its robust infrastructure and multidisciplinary expertise to facilitate innovative studies aimed at improving patient outcomes and contributing to the global body of medical knowledge. With a focus on ethical standards and scientific integrity, Sohag University collaborates with healthcare professionals and researchers to conduct trials that address critical health issues, ensuring the advancement of evidence-based practices in the healthcare community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported